The Valuation of Biotech IPOs
Authors:
- 1 October 2005
- journal article
- review article
- Published by SAGE Publications in Journal of Accounting, Auditing & Finance
- Vol. 20 (4) , 423-459
Abstract
The valuation of initial public offerings (IPOs) is of considerable interest, given the important role these enterprises play in economic growth and investors' decisions. IPO valuation is particularly challenging due to the meager information available about new enterprises at offering dates. We extend the research on IPO valuation in various directions. First, we penetrate deep beyond the traditional proxies for value drivers, such as R&D expenditures and cash flows, by defining and testing a host of specific product-related and competitive environment value drivers; second, we examine IPO valuations at three distinct phases of the going-public process; third, we employ both the direct valuation and relative valuation approaches; and fourth, we round up the analysis by examining the long-term performance of IPOs. Based on a sample of biotech IPOs from the 1990s, we document the overwhelming importance of product-related and intellectual property fundamentals, as well as the irrelevance of several key signals, such as venture capital backing and the quality of underwriters, which played prominent roles in previous research.Keywords
This publication has 31 references indexed in Scilit:
- Competitive Costs of Disclosure by Biotech IPOsJournal of Accounting Research, 2004
- IPO Valuation in the New and Old EconomiesSSRN Electronic Journal, 2003
- A Review of IPO Activity, Pricing, and AllocationsThe Journal of Finance, 2002
- Who Is My Peer? A Valuation‐Based Approach to the Selection of Comparable FirmsJournal of Accounting Research, 2002
- Managerial Actions, Stock Returns, and Earnings: The Case of Business‐to‐Business Internet FirmsJournal of Accounting Research, 2002
- The New Issues PuzzleThe Journal of Finance, 1995
- The underpricing of initial public offerings and the partial adjustment phenomenonJournal of Financial Economics, 1993
- The Cross‐Section of Expected Stock ReturnsThe Journal of Finance, 1992
- How investment bankers determine the offer price and allocation of new issuesJournal of Financial Economics, 1989
- A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for HeteroskedasticityEconometrica, 1980